Discover
FLNA
Filana Therapeutics, Inc.
1.25
2 x 1.23
1 x 1.24
bid
ask
+
0.06
5.04%
2 @ 07:42 AM
1.25 -0.00 (0.01%)
| Ytd | -36.87% | |
| 1y | -32.43% |
1.19
day range
1.26
1.15
52 week range
4.98
| Open | 1.19 | Prev Close | 1.19 | Low | 1.19 | High | 1.26 | Mkt Cap | 60.38M |
| Vol | 401.98K | Avg Vol | 379.98K | EPS | -1.61 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 1.35 | 200-d Avg | 2.26 | 1yr Est | 0.00 |
FLNA News
benzinga.com
Maxim Group Reinstates Buy on Filana Therapeutics, Announces $5 Price Target
Maxim Group analyst Jason McCarthy reinstates Filana Therapeutics (NASDAQ:FLNA) with a Buy and an
benzinga.com
Filana Therapeutics Q1 EPS $(0.21) Beats $(0.23) Estimate
Filana Therapeutics (NASDAQ:FLNA) reported quarterly losses of $(0.21) per share which beat the anal
benzinga.com
Filana Therapeutics Announces Publication In Epilepsia Of Preclinical Data Showing Simufilam Attenua
Study in a well-accepted mouse model of severe Tuberous Sclerosis Complex (TSC) showed that simufila